You have 9 free searches left this month | for more free features.

Auto Stem Cell Transplant

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Auto Stem Cell Transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

Completed
  • Non-Hodgkin's Lymphoma
  • Plasma Cell Myeloma
  • Hematopoietic Cell Transplantation
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
May 4, 2022

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Multiple Myeloma Trial in Washington, Hackensack (Melphalan, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Washington, District of Columbia
  • +1 more
May 6, 2022

Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell
  • fecal microbiota transplantation (FMT)
  • No fecal microbiota transplantation (FMT), routine management
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

Not yet recruiting
  • Acute Leukemia
  • Rifaximin with allogeneic stem cell transplant
  • Allogeneic stem cell transplant
  • (no location specified)
Sep 21, 2023

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Stem Cell Trial in Houston (Enteral nutrition (EN), Standard care parenteral nutrition (PN))

Recruiting
  • Stem Cell
  • Enteral nutrition (EN)
  • Standard care parenteral nutrition (PN)
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Intestinal Microbiota in Stem Cell Transplant Transplant

Recruiting
  • Stem Cell Transplant Complications
  • intestinal microbiota
  • Detroit, Michigan
    Henry Ford Health System
Dec 27, 2022

Development of Liver Dysfunction in Hematopoietic Stem Cell

Not yet recruiting
  • Hematopoietic Stem Cell Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2023

    Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Jul 18, 2022

    Myeloma Trial in Rochester (Hyperbaric oxygen)

    Recruiting
    • Myeloma
    • Hyperbaric oxygen
    • Rochester, New York
      James P. Wilmot Cancer Center at University of Rochester Medical
    May 5, 2022

    DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

    Recruiting
    • DOCK8 Deficiency
    • Reduced-intensity hematopoietic stem cell
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

    Not yet recruiting
    • Transplantation, Hematopoietic Stem Cell
    • Biological samples (blood and oral fluid)
    • Lyon, France
      Hôpital de la Croix Rousse - service des maladies infectieuses e
    Jul 7, 2023

    Cancer Trial in Boston (CARE, Standard Transplant Care)

    Active, not recruiting
    • Cancer
    • CARE
    • Standard Transplant Care
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 24, 2023

    Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

    Not yet recruiting
    • Myeloid Malignancy
    • Acute Myeloid Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer, Case Comprehensive Cancer C
    Nov 8, 2023

    Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Plasma Cell Leukemia
    • +3 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)

    Not yet recruiting
    • Hematopoietic Stem Cell Transplant
    • Cardio-oncology program
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jul 6, 2023

    Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

    Active, not recruiting
    • Chronic Granulomatous Disease Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

    Withdrawn
    • Leukemia
    • Donor Enriched Activated Natural Killer Cell Infusion
    • (no location specified)
    Dec 20, 2022